NovoCure (NVCR) Operating Income (2014 - 2026)
NovoCure recorded quarterly Operating Income of -$67.4 million in Q1 2026, down 66.91% quarter-over-quarter from -$40.4 million in Q4 2025, and down 78.05% year-over-year from -$307.2 million in Q1 2025.
NovoCure's Operating Income history runs 13 years deep, the most recent figure standing at -$67.4 million for Q1 2026.
- In Q1 2026, Operating Income fell 78.05% year-over-year to -$67.4 million; the TTM figure through Mar 2026 stood at -$183.4 million (down 9.9% YoY), while the FY2025 annual figure was -$153.8 million, up 9.79% from the prior year.
- Operating Income came in at -$67.4 million for Q1 2026 at NovoCure, down from -$40.4 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of -$806000.0 in Q1 2022 to a low of -$67.4 million in Q1 2026.
- A 5-year average of -$42.0 million and a median of -$40.4 million in 2025 frame the typical range for Operating Income.
- Across the five-year window, Operating Income plunged 7375.06% in 2023 and jumped 46.41% in 2024, its largest moves.
- NovoCure's Operating Income stood at -$43.0 million in 2022, then dropped by 20.33% to -$51.7 million in 2023, then dropped by 22.41% to -$63.3 million in 2024, then jumped by 36.19% to -$40.4 million in 2025, then slumped by 66.91% to -$67.4 million in 2026.
- According to Business Quant data, Operating Income over the past three periods registered -$67.4 million, -$40.4 million, and -$36.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.35 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 936.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 1.46 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.10 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 477.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 282.15 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 255.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 515.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 316.80 Mn |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn | -67.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -67.42 Mn |
| Dec 31, 2025 | -40.39 Mn |
| Sep 30, 2025 | -36.02 Mn |
| Jun 30, 2025 | -39.52 Mn |
| Mar 31, 2025 | -37.87 Mn |
| Dec 31, 2024 | -63.30 Mn |
| Sep 30, 2024 | -32.09 Mn |
| Jun 30, 2024 | -33.58 Mn |
| Mar 31, 2024 | -41.52 Mn |
| Dec 31, 2023 | -51.72 Mn |
| Sep 30, 2023 | -58.25 Mn |
| Jun 30, 2023 | -62.66 Mn |
| Mar 31, 2023 | -60.25 Mn |
| Dec 31, 2022 | -42.98 Mn |
| Sep 30, 2022 | -24.61 Mn |
| Jun 30, 2022 | -21.13 Mn |
| Mar 31, 2022 | -806,000.00 |
| Dec 31, 2021 | -23.40 Mn |
| Sep 30, 2021 | -8.55 Mn |
| Jun 30, 2021 | -12.30 Mn |
| Mar 31, 2021 | -88,000.00 |
| Dec 31, 2020 | 12.09 Mn |
| Sep 30, 2020 | 15.02 Mn |
| Jun 30, 2020 | 6.67 Mn |
| Mar 31, 2020 | -3.38 Mn |
| Dec 31, 2019 | 153,000.00 |
| Sep 30, 2019 | 3.86 Mn |
| Jun 30, 2019 | 1.20 Mn |
| Mar 31, 2019 | -6.12 Mn |
| Dec 31, 2018 | -8.66 Mn |
| Sep 30, 2018 | -5.25 Mn |
| Jun 30, 2018 | -7.09 Mn |
| Mar 31, 2018 | -12.68 Mn |
| Dec 31, 2017 | -4.51 Mn |
| Sep 30, 2017 | -5.92 Mn |
| Jun 30, 2017 | -15.53 Mn |
| Mar 31, 2017 | -13.37 Mn |
| Dec 31, 2016 | -17.88 Mn |
| Sep 30, 2016 | -28.27 Mn |
| Jun 30, 2016 | -37.24 Mn |
| Mar 31, 2016 | -31.94 Mn |
| Dec 31, 2015 | -30.61 Mn |
| Sep 30, 2015 | -24.24 Mn |
| Jun 30, 2015 | -27.21 Mn |
| Mar 31, 2015 | -21.95 Mn |
| Dec 31, 2014 | -23.01 Mn |
| Sep 30, 2014 | -17.91 Mn |